The channel of NMDA receptors is blocked by a wide variety of drugs. NMDA receptor channel blockers include drugs of abuse that induce psychotic behavior, such as phencyclidine, and drugs with wide therapeutic utility, such as amantadine and memantine. We describe here the molecular mechanism of amantadine inhibition. In contrast to most other described channel-blocking molecules, amantadine causes the channel gate of NMDA receptors to close more quickly. Our results confirm that amantadine binding inhibits current flow through NMDA receptor channels but show that its main inhibitory action at pharmaceutically relevant concentrations results from stabilization of closed states of the channel. The surprising variation in the clinical utility of NMDA channel blockers may in part derive from their diverse effects on channel gating.
Introduction
Amantadine is a drug of broad clinical utility. It was first recognized as an antiviral agent (Davies et al., 1964) but soon afterward was also found to be useful in treating Parkinson's disease (Schwab et al., 1969) . It continues to be a widely used and well tolerated drug in the treatment of parkinsonian movement disorders and may also slow the progression of Parkinson's disease (Blanchet et al., 2003) , ameliorate chronic pain (Fisher et al., 2000) , and improve recovery from traumatic brain injury (Meythaler et al., 2002) .
The clinical utility of amantadine appears to result from its actions as a blocker of ion channels. Its antiviral action results from block of the M2 small viral membrane protein (Hay, 1992) . Although the utility of amantadine in treating Parkinson's disease was initially assumed to result from effects on dopaminergic systems (Danysz et al., 1997) , amantadine later was found to block the channel of NMDA receptors (Kornhuber et al., 1991; Lupp et al., 1992; Parsons et al., 1995; Blanpied et al., 1997) . Increasing evidence suggests that the effectiveness of amantadine in treating nervous system disorders results predominantly from its inhibition of NMDA responses (Blanchet et al., 2003) .
NMDA receptor channel blockers have diverse properties. Channel block by extracellular Mg 2ϩ is of profound physiological significance because it is responsible for the powerful voltage dependence of postsynaptic Ca 2ϩ influx at excitatory synapses (Dingledine et al., 1999) . In contrast to clinically useful NMDA receptor channel blockers such as amantadine and its derivative memantine, many organic blockers, such as ketamine and phencyclidine, induce schizophrenic-like behavior in humans (Jentsch and Roth, 1999) and are neurotoxic (Olney et al., 1999) . Why do substances with an apparently similar pharmacological action, channel block of NMDA receptors, exhibit such divergent clinical properties? Previous data suggest that possible variations in either nonspecific drug actions or in NR2 subunit specificity do not provide adequate explanations (Javitt and Zukin, 1991; Bresink et al., 1996; Danysz et al., 1997; Monaghan and Larsen, 1997; Blanchet et al., 2003) . Instead, the wide variation in clinical utility may arise from differences in the mechanisms of blocker interaction with NMDA receptors. Aspects of mechanism that can powerfully influence inhibitory properties of a channel blocker include the kinetics and affinity of blocker binding and the effects of bound blocker on transitions among channel closed states (Rogawski, 1993; Parsons et al., 1999b; Johnson and Qian, 2002) . Despite the importance of these aspects of blocker action, we currently have limited understanding of the interaction between NMDA receptors and amantadine.
In this paper, we combined whole-cell and single-channel recording with quantitative modeling to investigate the mechanisms by which amantadine inhibits NMDA responses. We found that amantadine displays intermediate kinetics of block (Hille, 2001) , which permitted us to measure blocking and unblocking rates and estimate rate of channel closure with amantadine bound. We show that, when amantadine is bound in the channel of NMDA receptors, it increases the rate of channel closure. As a result, the predominant inhibitory mechanism of amantadine is not blockade of current flow through open channels but rather increasing occupancy of channel closed states. The unusual properties of amantadine may play an important role in its clinical safety.
briefer. In 100 M amantadine, which increased the frequency of openings briefer than t min , o was 70 Ϯ 2% of the unadjusted arithmetic mean open time.
Closed-time histograms in the absence and in the presence of amantadine were well fit in the large majority of cases by the sum of three exponential components. In the absence of amantadine, these components had time constants as follows: short duration ( C,S ), 0.29 Ϯ 0.04 ms; intermediate duration ( C,I ), 7.22 Ϯ 1.70 ms; long duration ( C,L ), 494 Ϯ 80 ms; with relative amplitudes of 0.43 Ϯ 0.02, 0.16 Ϯ 0.01, and 0.41 Ϯ 0.02, respectively. As described in Results, the mean duration of amantadine blocking events ( C,B ) was similar to C,S . The accuracy of estimates of C,B were optimized by establishing conservative criteria for acceptance of data to be used in the estimates. The criteria were used to minimize two potential errors. The first potential error resulted from the similarity of C,S and C,B . These two closed-time components were too similar to be fit by separate exponentials but in general should not have identical durations. Thus, short-duration channel closures could have interfered with measurement of C,B . To minimize interference from these brief closures, we accepted C,B measurements only if the shortduration component area was Ͼ70% of the total area of all closed-time components (see Fig. 2C ). With this cutoff, approximately two-thirds or more of the short-duration component were attributable to amantadine block. The second possible error was overestimation of C,B because of missed brief openings at high concentrations of amantadine. To minimize this error, we accepted C,B measurements only when O,B was Ͼ0.5 ms (Antonov and Johnson, 1996) , limiting missed openings to a maximum of 18% of all openings. Because the number of missed openings increases with amantadine concentration, the observation that the estimated C,B does not increase with amantadine concentration (see Fig.  2 B) supports the accuracy of our estimate. Only data in 10 M (6 of 8 patches) and 30 M amantadine (7 of 11 patches) satisfied the criteria described above. Data that met both these criteria are superimposed on all single-channel data in Figure 2 , B and C.
The value of 1/ C,B provides an estimate of the sum of rates for leaving the blocked state (Colquhoun and Hawkes, 1995) , which according to model 1, is ␣Ј ϩ k Ϫ . Our use of 1/ C,B as an estimate of k Ϫ alone is based on the assumption that k Ϫ Ͼ Ͼ ␣Ј. Analysis of burst durations indicated that ␣Ј is 251 s Ϫ1 (see Results). Because this is much smaller than the estimated value of 1/ C,B (4480 s Ϫ1 ), the approximation k Ϫ ϭ 1/ C,B should be in error by Ͻ6%.
n ϫ P open (number of channels in a patch multiplied by mean open probability per channel) was calculated as total channel open time divided by recording time using pClamp 9 (Axon Instruments). The patch recording durations used here ranged from 71 to 335 s (mean of 163 s).
Burst analysis was performed to estimate the rate of channel closure in the absence and presence of amantadine. Burst durations were measured as the duration of openings with closures briefer than a critical duration (t crit ) counted as part of open time (Colquhoun and Sigworth, 1995) . Only patches in which Ͻ5% of all openings were multilevel openings were used. In the absence of amantadine, channel openings of NMDA receptors are often interrupted by short-duration closures (time constant C,S ). These short-duration closures constitute a trivial fraction of total closed time. This state therefore was ignored by choosing a t crit between C,S and C,I (Dilmore and Johnson, 1998) and was not represented in the model we used for data analysis (see Fig. 3A ). As a result, channel closures were defined as transitions to closed states of intermediate or longer duration. To minimize the unavoidable error of misclassification of closures, t crit was calculated so that there were equal numbers of shortduration closures counted as between burst and intermediate closures counted as within burst (Magleby and Pallotta, 1983) . Values for t crit in control conditions were 1.23 Ϯ 0.33 ms, in good agreement with values obtained in previous studies of forebrain neurons (Howe et al., 1988; Jahr and Stevens, 1990; Gibb and Colquhoun, 1992; Kleckner and Pallotta, 1995; Antonov and Johnson, 1996) . The average separation of C,S and C,I by a factor of 27 is somewhat less than preferred for burst analysis (Colquhoun and Sigworth, 1995) . However, burst duration showed little sensitivity to small variations in t crit : doubling t crit increased burstduration estimates by only 9.0 Ϯ 1.8%, whereas halving t crit decreased burst-duration estimates by only 10.5 Ϯ 1.3% (n ϭ 6 patches). These results suggest that burst-duration estimates were reliable. In 1 of 32 patch data segments used for burst analysis, the middle closed-time component was Ͻ1 ms and was included within bursts. Burst analysis in the presence of amantadine was designed to count amantadine blocking events as within burst. Because the value of C,B was very close to the value of C,S , the procedures used were identical to those used in the absence of amantadine. The mean values of t crit in amantadine (1.02 Ϯ 0.11 ms in 10 M, 1.19 Ϯ 0.13 ms in 30 M, and 1.45 Ϯ 0.06 ms in 100 M amantadine) were similar to the control value (1.23 Ϯ 0.33 ms).
Whole-cell recording. Whole-cell recordings from cultured neurons or transfected HEK 293T cells were performed as described previously (Blanpied et al., 1997) , using the same solutions as for outside-out patch recordings. Rapid applications of the indicated NMDA concentration plus 10 M glycine with or without amantadine were accomplished by moving a set of gravity-fed flow pipes under computer control. Solution exchanges were at least 98% complete within 120 ms (Blanpied et al., 1997) .
All experiments were performed at room temperature.
Curve fitting and modeling. Concentrationinhibition curves were constructed by fitting data with the following equation:
where Response is either normalized n ϫ P open (see Fig. 2 D) or I Aman / I Control (see Fig. 4 B) , [Aman] is the amantadine concentration, IC 50 is the [Aman] at which the response is 50% inhibited, and n H is the Hill coefficient, which reflects the cooperativity of drug action.
The equilibrium predictions of model 1 (see Fig. 3A ) shown in Figures  3 , B and C, 5, and 6 D were made with the equations derived in the supplemental material (available at www.jneurosci.org). The equilibrium constants among unblocked channel states (K a ϭ 11.0 M; K g ϭ 39.0; K ds ϭ 0.2) were fixed at values chosen as described previously (Dilmore and Johnson, 1998 ) based on previous measurements (Benveniste and Mayer, 1991; Lester et al., 1993; Rosenmund et al., 1995) . Because estimates of maximal P open (which is established by K g ) for NMDA receptors have varied greatly, a value for K g could not be set with confidence. However, the predictions based on model 1 shown in Figures  3C , 5, and 6 D varied only slightly when K g was varied from 39 [corresponding to a maximal P open of 0.025 (Rosenmund et al., 1995) ] to 2.33 [corresponding to a maximal P open of 0.3 (Jahr, 1992) ]. Similarly, our general conclusions are not affected by changes in the values of K a or K ds within a plausibly physiological range. The K d of amantadine was fixed at 110 M, which equals the ratio of rate constants (k Ϫ /k ϩ ) determined here from single-channel measurements. Equilibrium constants among blocked channel states were set to equal the corresponding equilibrium constants for unblocked channels, except when otherwise indicated. Burst-duration fitting and predictions (see Fig. 6C ) were made with Equation 2, which is derived in the supplemental material (available at www.jneurosci.org).
Predictions from and fitting of equations were performed in Origin 7 (OriginLab, Northampton, MA) or SigmaPlot 8 (SPSS, Chicago, IL). Errors in text and error bars in figures indicate SEM.
Results

Rates of amantadine block and unblock
We investigated the kinetics of block by 3-100 M amantadine of single channels activated by 5 M NMDA plus 10 M glycine in outside-out patches at a holding potential of Ϫ67 mV. Amantadine did not affect the single-channel current amplitude of open NMDA-activated channels but induced brief, flickering closures that interrupted channel openings (Fig. 1 A) . As amantadine concentration was increased, the frequency of brief closures increased, causing a decrease in the duration of channel openings ( Fig. 1 A, B) . The population of brief closures observed in the presence of amantadine ( Fig. 1 A, C) are typical of open channel blocking drugs with "intermediate" kinetics (Hille, 2001) . We took advantage of the kinetics of amantadine block to measure (Neher and Steinbach, 1978 ) the apparent rate constants of amantadine block (k ϩ ) and unblock (k Ϫ ) directly from singlechannel recordings.
To estimate k ϩ , we measured the mean duration of channel openings ( O ) in the absence (control, O,C ) and presence (blocker, O,B ) of amantadine ( Fig. 1 B) . As expected for an openchannel blocker (Neher and Steinbach, 1978) (Fig. 2 A) , was 40.8 M Ϫ1 s Ϫ1 . We estimated k Ϫ from the mean duration of the closures induced by amantadine ( C,B ), which reflects its dwell time in the channel, and applied the equation (Neher and Steinbach, 1978) k Ϫ ϭ 1/ C,B . Closed-time distributions in both the absence and presence of amantadine were well fit by the sum of three exponential components (Fig. 1C) . Amantadine appeared to cause an increase in the frequency of the shortest-duration closures (Fig.  1C ). We concluded that this effect of amantadine results from similarity of the value of C,B and the mean duration of the shortestduration closures in the absence of amantadine based on the following observations: (1) amantadine had little effect on the mean dura- tion or relative area of the longer components of the closed-time distribution (Fig. 1C) ; (2) 
Divergence of K d and IC 50 of amantadine
With the above data, the equilibrium dissociation constant for binding of amantadine to the open channel of NMDA receptors (K d ) can be estimated (Hille, 2001 ) from the equation
This K d is considerably larger than the amantadine IC 50 (38.9 Ϯ 4.6 M) that we measured under similar conditions in whole-cell experiments (Blanpied et al., 1997) , a value in agreement with the average amantadine IC 50 (ϳ35 M) measured electrophysiologically by others (Parsons et al., 1995 (Parsons et al., , 1999a Sobolevsky and Yelshansky, 2000; Bolshakov et al., 2003) . The observation that K d Ͼ IC 50 implies that amantadine inhibits total NMDA receptor-mediated current more effectively than it blocks open single channels.
One possible explanation for the difference between the K d of amantadine (measured in patch experiments) and IC 50 (measured in whole-cell experiments) is that patch excision increases the IC 50 of amantadine, as observed for NMDA receptor channel block by internal Mg 2ϩ (Li-Smerin et al., 2000 , 2001 . If this explanation were correct, then the IC 50 of amantadine measured in outside-out patches should resemble the K d , 110 M. We tested this possibility by measuring the amantadine concentration dependence of the total channel open time (n ϫ P open ) during outside-out patch recordings. Fitting of Equation 1 to normalized n ϫ P open (Fig. 2 D) yielded an IC 50 of 29.7 M (n H ϭ 1.1), in reasonable agreement with previous whole-cell IC 50 measurements. This result conflicts with the hypothesis that patch excision increases the IC 50 of amantadine and suggests that an explanation for the discrepancy between K d and IC 50 should be sought in the mechanism of amantadine action.
The relationship between the K d and IC 50 of a channel blocker depends on how the blocker affects channel transitions after binding. For example, blockers that act by the "sequential" (or "foot-in-the-door") mechanism, which prevent closure of the channel while blocking, inhibit whole-cell responses (or patch n ϫ P open ) much less effectively than they block single-channel currents (K d Ͻ Ͻ IC 50 ) (Neher and Steinbach, 1978; Hille, 2001; Johnson and Qian, 2002) . Amantadine, in contrast, is known to be a trapping channel blocker: it permits channel closure while bound in the channel of NMDA receptors (Blanpied et al., 1997; Sobolevsky and Yelshansky, 2000; Bolshakov et al., 2003) . Nevertheless, even trapping channel blockers have been found to partly inhibit channel closure during block , leading to an IC 50 that is greater than the K d . However, for amantadine, K d is greater than IC 50 , a difference that cannot be the result of partial inhibition of channel closure.
The observation that K d Ͼ IC 50 for amantadine is inconsistent with the hypothesis that it inhibits NMDA responses simply by blocking current flow through the channel. This inequality implies that nonconducting states with amantadine bound (which do not exist for a sequential blocker) are of great importance to its mechanism of action. To better understand how amantadine inhibits NMDA responses, we used a trapping channel block model, which includes closed, amantadine-bound states. By combining model simulations with whole-cell and singlechannel data, we tested whether this model can account for the difference between the IC 50 and K d of amantadine.
The trapping channel block model we used (Fig. 3A) is derived from previous work on channel block of NMDA receptors (Benveniste and Mayer, 1995; Blanpied et al., 1997; Chen and Lipton, 1997; Dilmore and Johnson, 1998; Sobolevsky and Yelshansky, 2000) and nicotinic ACh receptors (Lingle, 1983; Ogden and Colquhoun, 1985) . The upper five states of model 1 describe the behavior of NMDA receptors in the absence of blocker, whereas the lower five states describe the ability of amantadine to be trapped in closed channels. The model does not include binding steps for glycine because a saturating glycine concentration was included in all solutions. The model compresses multiple closed, liganded, nondesensitized states into a single state, A 2 R (see Discussion). Faithful reproduction of NMDA receptor behavior under all conditions clearly would require a much more complex model. However, there currently is insufficient understanding of NMDA receptors to develop a full and accurate model. Model 1 has been found to reproduce with surprising accuracy a wide range of properties of NMDA receptors and channel blockers and to be highly useful for hypothesis testing (Dilmore and Johnson, 1998; Anson et al., 2000) .
We applied model 1 to determine whether, and if so how, the relatively low IC 50 with which amantadine inhibits whole-cell NMDA responses can be explained by its known action as a trapping blocker. Because the model was used to simulate steady-state whole-cell measurements, consideration only of equilibrium constants (not rate constants) was needed. To minimize the number of adjustable parameters, the constants that defined equilibria among unblocked states (K a , K ds , and K g ) were fixed as described in Materials and Methods, and K d was fixed at 110 M based on the above single-channel measurements. We determined whether amantadine could lower its IC 50 relative to its K d by affecting any one of the three remaining constants, all of which defined equilibria among blocked states: agonist binding (KЈ a K a ), desensitization (KЈ ds K ds ), or channel gating (KЈ g K g ). To examine how these alterations of the equilibria among blocked states affect inhibition by amantadine, we used model 1 to predict amantadine concentration-inhibition curves (for the equation used and its derivation, see supplemental material, available at www.jneurosci.org). Figure 3B shows an example of simulated concentration-inhibition relationships for amantadine when the gating equilibrium constant (KЈ g ) was changed to 0.1 ϫ K g or to 10 ϫ K g . Importantly, setting KЈ g ϭ 0.1 ϫ K g (that is, shifting the equilibrium between open and closed states toward the closed state, which we refer to as stabilizing the closed state), lowers the IC 50 . This plot demonstrates that inhibition by a trapping channel blocker is not solely determined by its obstruction of current flow but is strongly dependent on how it interacts with the gating machinery of a receptor. Despite its K d of 110 M for the open channel, the macroscopic IC 50 of 38.9 M of amantadine in the presence of 5 M NMDA could be explained if the presence of the drug in the channel altered any of the three blocked channel equilibrium constants (Fig. 3C) .
Dependence of amantadine IC 50 on NMDA concentration
The simulations of Figure 3 , B and C, show that the low IC 50 of amantadine can be explained parsimoniously through its known action as a trapping channel blocker, as described by model 1. We next wanted to determine which receptor state transition (agonist binding, channel gating, or desensitization) might be affected by amantadine binding. We used model 1 to search for an experimental protocol that would distinguish which equilibrium among receptor states is affected by amantadine binding. We found that the dependence of the IC 50 of amantadine on agonist concentration diverges strongly depending on which equilibrium is affected by amantadine binding. Therefore, we compared the IC 50 of amantadine at several different NMDA concentrations.
We reported previously (Blanpied et al., 1997 ) that, in 5 M NMDA, the IC 50 of amantadine was 38.9 Ϯ 4.2 M, and its Hill coefficient (n H ) was 0.99 Ϯ 0.02 (n ϭ 6). Here we used the same whole-cell protocol, membrane potential (Ϫ67 mV), and solutions as used previously to measure the IC 50 of amantadine in 30 M NMDA (Fig. 4 A, B) . The IC 50 was 50.5 Ϯ 11.5 M, with n H ϭ 0.99 Ϯ 0.04 (n ϭ 3). We attempted to make similar measurements at 1000 M NMDA, but strong rundown of the response prevented reliable measurement of full concentrationinhibition relationships. We instead used a single amantadine concentration of 50 M to estimate its IC 50 in 1000 M NMDA. To ensure the reliability of this estimate, we used the same protocol to make a second estimate of the amantadine IC 50 in 30 M NMDA (Fig. 4C ). Amantadine at 50 M inhibited the response to 30 M NMDA by 55 Ϯ 6% and the response to 1000 M NMDA by 47.9 Ϯ 6%. These values were used to estimate IC 50 using the relationship IC 50 ϭ [amantadine] ϫ (1 Ϫ f )/f, where f is fractional inhibition by 50 M amantadine, yielding the following: in 30 M NMDA, amantadine IC 50 ϭ 45.1 Ϯ 11.3 M; and in 1000 M NMDA, amantadine IC 50 ϭ 54.3 Ϯ 16.5 M. The two estimates of IC 50 in 30 M NMDA are not statistically different and so were combined, giving an estimate of 47.8 Ϯ 7.3 M (n ϭ 6). There were no significant differences between any of the amantadine IC 50 estimates in 5, 30, and 1000 M NMDA, even when correction for multiple comparisons was not performed. Thus, these results indicate that the IC 50 of amantadine does not depend significantly on NMDA concentration.
To help interpret these data, they are plotted with model 1 predictions of the relationship between IC 50 and NMDA concentration (Fig. 5) . Amantadine was assumed to have a K d of 110 M and to achieve an IC 50 of 38.9 M in 5 M NMDA by only decreasing NMDA affinity (long dashes; IC 50 rises with NMDA concentration), only stabilizing the channel closed state (short dashes; IC 50 is nearly insensitive to NMDA concentration), or (k) are shown in the model. Equilibrium constants were defined as follows: for NMDA binding, K a ϭ k aϪ /k aϩ and KЈ a ϭ kЈ aϪ /kЈ aϩ ; for channel gating, K g ϭ ␣/␤ and KЈ g ϭ ␣Ј/␤Ј; for desensitization, K ds ϭ k dsϪ /k dsϩ and KЈ ds ϭ kЈ dsϪ /kЈ dsϩ ; for amantadine binding, K d ϭ k Ϫ /k ϩ . B, Model 1 was used to investigate how the IC 50 of a trapping channel blocker is influenced by the effects of the blocker on channel gating with [A] ϭ 5 M. Predicted concentration-response curves (see Materials and Methods) are plotted for a blocker with K d ϭ 110 M that has no effect on channel gating when bound (KЈ g ϭ K g ϭ 39; solid line), that stabilizes the channel open state (KЈ g ϭ 0.1 ϫ K g ; dashed line), and that stabilizes the channel closed state (KЈ g ϭ 10 ϫ K g ; dotted line). In all plots, KЈ a ϭ K a ϭ 11 M and KЈ ds ϭ K ds ϭ 0.2. C, Model 1 was used to determine that a blocker with K d ϭ 110 M can achieve an IC 50 of 38.9 M by decreasing agonist affinity (KЈ a ϭ 2.35 ϫ K a ϭ 25.9 M) alone, by stabilizing the channel closed state (KЈ g ϭ 2.83 ϫ K g ϭ 110) alone, or by stabilizing the desensitized state (KЈ ds ϭ 0.152 ϫ K ds ϭ 0.0304) alone.
only stabilizing the desensitized state (dots; IC 50 decreases with NMDA concentration). The measured IC 50 values strongly favor the model in which amantadine binding stabilizes the channel closed state. The data show a nonsignificant trend toward a rise in IC 50 as NMDA concentration increases. Model 1 similarly predicts that, if amantadine binding stabilized the channel closed state, IC 50 should rise with NMDA concentration, although the increase is too slight to be visible in Figure 5 (short dashes). This increase, however, depends on the value of K g . The value of K g used here, 39, corresponds to the previously estimated (Rosenmund et al., 1995) maximal P open of 0.025. If a lower K g (corresponding to a higher maximal P open , as has been reported in other studies) were assumed, then IC 50 would be predicted to rise slightly more steeply with NMDA concentration.
Effect of amantadine on the closing rate of blocked channels
The data and models above are consistent with the hypothesis that amantadine inhibits NMDA responses by stabilizing the channel closed state as well as by blocking the channel. Next, we tested a prediction of this hypothesis. If amantadine stabilizes the channel closed state, it must do so by decreasing the rate of channel opening (␤Ј Ͻ ␤ in model 1), by increasing the rate of channel closing (␣Ј Ͼ ␣), or by a combination of these two effects. We explored the possibility that amantadine increases the channel closing rate by measuring single-channel burst duration as a function of amantadine concentration.
As shown in Figure 1 A, in the presence of amantadine, NMDA receptor openings occur as "bursts," channel openings interrupted by brief closures that represent block by amantadine. The durations of bursts were estimated from the duration of channel openings when channel blocking events were ignored (Neher and Steinbach, 1978) . This burst duration approximates the time spent in states A 2 R* and A 2 R*B (model 1). In the absence of amantadine, the mean burst duration (t burst ) represents the mean duration of state A 2 R*, the inverse of which was used to estimate ␣ (see Materials and Methods). In a saturating concentration of amantadine, t burst , if it could be measured, would represent the mean duration of state A 2 R*B, the inverse of which would provide an estimate of ␣Ј. Burst duration in a saturating concentration of amantadine cannot be measured because the channel would essentially always be in a blocked state. However, t burst can be measured in intermediate amantadine concentrations; as amantadine concentration is increased from 0, model 1 predicts that t burst should change from a value of 1/␣ to values intermediate between 1/␣ and 1/␣Ј. Thus, if channel block by amantadine accelerates the rate of channel closure (that is, if ␣Ј Ͼ ␣), then burst duration should decrease as amantadine concentration increases. Note that this is the opposite of the predicted and observed effect of sequential blockers on burst duration (Neher and Steinbach, 1978; Antonov and Johnson, 1996) .
To test this prediction, standard procedures were used to measure burst duration, which involved measuring the open time after ignoring all closures briefer than a "critical gap length" (t crit ; see Materials and Methods). Figure 6 A shows examples of singlechannel openings, and Figure 6 B shows the corresponding burstduration distributions, in the absence and presence of amantadine. The burst-duration distribution in all conditions was adequately fit by the sum of one or two exponentials. We quantified t burst here as arithmetic mean because Equation 2 (below), which was derived from model 1 to fit the amantadine concentration dependence of t burst (see supplemental material, available at www.jneurosci.org), applies to arithmetic mean burst duration. In the absence of amantadine, t burst was 7.93 Ϯ 0.77 ms (n ϭ 10), which is near the middle of the range of previous estimates of NMDA receptor t burst from forebrain neurons Howe et al., 1988; Gibb and Colquhoun, 1992; Antonov and Johnson, 1996) . Consistent with the hypothesis that closed states are stabilized during amantadine block, t burst was decreased in all amantadine concentrations tested (Fig. 6C) , and there was significant negative correlation between amantadine concentration and t burst (Spearman's r; one-tailed p ϭ 0.023).
To further test the hypothesis that channel closure is accelerated by amantadine block, we determined whether the amantadine dependence of t burst (Fig. 6C) could be reproduced by model 1 by only increasing ␣Ј. To quantify the expected dependence of t burst on the concentration of a blocker that affects channel closing rate, we derived the following equation (see supplemental material, available at www.jneurosci.org) from model 1:
We fit the equatio to the data plotted in Figure 6C with ␣Ј as the only adjustable parameter (see legend to Fig. 6C ). The best fit was achieved with a value of 251 s Ϫ1 for ␣Ј, indicating that the burst duration in a saturating amantadine concentration would be 3.98 ms. These results indicate that the channel of NMDA receptors closes 1.99 times faster when blocked by amantadine than when unblocked. The agreement of this highly constrained fit of Equation 1 (solid line) with the data further supports the hypothesis that channel closure is accelerated during block by amantadine.
Does this effect of amantadine on channel closing fully explain the low IC 50 of amantadine? Probably not entirely. To achieve an IC 50 of 39 M at 5 M NMDA with a K d of 110 M through an effect only on channel gating, KЈ g must be 2.83 times greater than K g (Fig. 3C ). To achieve this difference purely through an effect on the rate of channel closure, amantadine would have to increase the channel closing rate by a factor of 2.83. The resulting effect on burst duration, predicted with Equation 1, is plotted in Figure 6C (dashed line). The difference between the dashed line and the data suggests that acceleration of channel closure is not the only mechanism by which amantadine reduces open probability. For example, if amantadine also reduced channel opening rate by a factor of 1.4 (␤Ј ϭ ␤/1.4), the observed difference between IC 50 and K d would result.
The whole-cell, single-channel, and modeling results presented here all support the hypothesis that amantadine inhibits NMDA responses with an IC 50 lower than its K d predominantly through an effect on channel gating. Amantadine thus has two inhibitory actions: blocking current flow through the open channel and increasing occupancy of closed states. Which is the dominant inhibitory mechanism by which amantadine acts? This question can be addressed be comparing the predicted concentration-response curves of two hypothetical antagonists. Both bind to the open state of the NMDA receptor with the K d of amantadine (110 M). However, one is a pure channel blocker: it does not affect receptor function (KЈ g 
The other is a pure "gating antagonist": it stabilizes the closed state of the NMDA receptor like amantadine but does not block current flow through the open channel. The predicted concentration-inhibition curves for these hypothetical blockers and for amantadine are compared in Figure 6 D. For inhibitor concentrations below ϳ100 M, the gating antagonist ("Gating Only") inhibits more effectively than the antagonist that blocks current flow without affecting gating ("Block Only"). Thus, over the range of amantadine concentrations that are pharmaceutically relevant, the principal antagonistic effect of amantadine is to stabilize the closed state of the channel of NMDA receptors.
We performed one additional test of the hypothesis that amantadine increases channel closing rate when bound. The test is based on the observation that, after block of NMDA receptor channels by extracellular Mg 2ϩ (Mg ments. Kinetic models were used to explore possible explanations for these observations (Kampa et al., 2004; Vargas-Caballero and Robinson, 2004) . It was found that slow components of unblock are expected if blocker binding increases the occupation of channel closed states. Occupation of closed states was increased by either increasing the rate of channel closure (Vargas-Caballero and Robinson, 2004) or modifying multiple rate constants, including the rate of channel closure (Kampa et al., 2004) . Based on these results, our hypothesis that amantadine accelerates channel closure, and hence increases occupation of closed states, predicts that amantadine unblock after a depolarizing voltage jump should proceed with a multi-exponential time course.
We tested this prediction as shown in Figure 7 and Table 1 . These experiments were performed on transfected HEK 293T cells, which are electrotonically compact, rather than neurons because excellent space clamp was important to avoid artifactual slow relaxations after the voltage jumps. We transfected the NR2B subunit (along with NR1-1a) because this is likely to be the dominant NR2 subunit in the cultured neurons used in other experiments (Zhong et al., 1994) . The unblocking rate of amantadine, which should be even faster at 40 mV than at Ϫ67 mV, would cause unblocking time course to be submillisecond if amantadine block had no effect on receptor transition rates (Kampa et al., 2004; Vargas-Caballero and Robinson, 2004) . In contrast, we observed prominent slow components to amantadine unblock at 40 mV (Fig. 7 unblock. These data support the idea that channel block by amantadine increases the occupation of closed states by increasing the rate of channel closure.
Discussion
A crucial feature of clinically useful drugs is an affinity for their target molecule(s) that is high enough to prevent undesirable nonspecific effects. The affinity of a drug can be increased through increasing its binding rate or decreasing its unbinding rates. Because binding rates are limited, most fundamentally by diffusion, clinically useful drugs tend to unbind relatively slowly.
The data presented here demonstrate that amantadine binds to its principal target, the open channel of NMDA receptors, with a binding rate typical of channel blockers, ϳ40 M Ϫ1 s Ϫ1 at resting potential. The corresponding unbinding rate of amantadine, however, is remarkably fast at over 4000 s Ϫ1 . How does a drug with such a fast unbinding rate nevertheless exhibit inhibitory effects on its target in a useful concentration range? The answer shown here is that, after blocking the open channel, amantadine encourages NMDA receptor channels to occupy closed conformations. This unusual ability of amantadine increases its affinity, despite its fast unbinding from receptors with an open channel.
The principal mechanism by which amantadine inhibits NMDA responses at clinically useful concentrations is atypical of characterized channel blockers, which by definition plug open channels. Inhibition of NMDA responses by amantadine at concentrations below 100 M, in contrast, depends mostly on stabilization of channel closed states. Thus, the principal mode of action of amantadine is that of a gating antagonist rather than channel blocker. Burst analysis (Fig. 6C) revealed that the main mechanism by which amantadine stabilizes channel closed states is through acceleration of channel closure by a factor of ϳ2. Observation of a slow component of amantadine unblock after a depolarizing voltage jump (Fig. 7) supported the idea that amantadine binding accelerates channel closure. Additional support for this idea can be found in our previous study of inhibition by memantine and amantadine of whole-cell NMDA-activated currents (Blanpied et al., 1997) . The best fit of a simplified version of model 1 to whole-cell responses during agonist and amantadine concentration jumps yielded channel closing rates that were 2.9 times faster when amantadine was bound. Thus, although amantadine binding and unbinding rates were unknown in the previous study, its modeling results were consistent with the results obtained here using burst analysis.
Acceleration of channel closure cannot fully explain the low IC 50 of amantadine, which requires that block by amantadine stabilize the closed state by a factor of 2.8 (Fig. 3C) . It is possible that amantadine slows channel opening rate as well as accelerating channel closing rate. We cannot exclude the possibility, however, that amantadine has other inhibitory effects on NMDA receptors, although any additional inhibitory actions are unlikely to be at the NMDA binding site (Fig. 5) .
Although only a single closed-liganded state (A 2 R) is shown in the absence of blocker in model 1, NMDA receptors are known to have access to multiple closed-liganded states (Gibb and Colquhoun, 1992) . The shortest-duration closed state that we observed, which was not included in model 1, was briefer than t crit and so could not have terminated bursts. Shortening of burst duration by amantadine therefore must have resulted from increased occupancy of longer-lived closed states. It is possible that a new longer-lived closed state appears only when amantadine is bound. However, a simpler explanation would appear to be that entry into a state or states that also exist in the absence of amantadine is accelerated. Although understanding of connections among NMDA receptor closed states is limited, an explicit model to explain three components of closed-time histograms was pro- o (thin trace). Cells were exposed to the indicated external solution starting 15 s before the voltage jump. Currents were leak and capacitive subtracted using identical voltage steps made in the presence of blocker but in the absence of agonists. In A, currents are not normalized; in B, currents were normalized and shifted so that currents were equal before the voltage jump and also at steady state at 40 mV (not visible in plotted section of traces). Normalization was particularly important to remove differences attributable to Mg 2ϩ o potentiation of NR1/NR2B receptors (Paoletti et al., 1995) .
posed in an impressive recent study (Banke and Traynelis, 2003) . In this model, open channels can close only to the shortest-lived closed state; from this state, either NR1 or NR2 subunits can make transitions to longer-lived closed conformations. The closed durations reported here differ from those recorded under different conditions by Banke and Traynelis (2003) . Nevertheless, our burst data could be plausibly explained within the framework of their model if channel block by amantadine increases the rate of any of the three proposed types of closing transitions. Because amantadine binds in the channel, the most straightforward idea may be that amantadine increases the reverse rate of the final, rapid, concerted, pore-opening transition. This would mean that amantadine increases the rate into the shortest-lived state, the duration of which would be within burst. However, in this model, the shortest-lived state is a gateway state to all other closed states. Thus, increasing occupancy of the shortest-lived state would result in an increase in the rate of entry into longerlived states and would lead to shorter bursts.
Many organic NMDA receptor channel blockers affect channel gating (for review, see Johnson and Qian, 2002; Sobolevsky, 2003) . However, occupation of the channel of NMDA receptors by organic channel blockers has been shown by previous studies to stabilize the channel open state. Amantadine appears to be the first organic NMDA receptor channel blocker to be shown to stabilize closed states. In contrast to most organic blockers, physiological block of NMDA receptor channels by Mg 2ϩ o was proposed recently to accelerate channel closure (Kampa et al., 2004; Vargas-Caballero and Robinson, 2004) . This proposal was supported by earlier measurements of an Mg 2ϩ o -induced decrease in burst duration Kampa et al., 2004) . Also, in contrast to amantadine, the IC 50 and K d of Mg 2ϩ o are nearly identical . This observation and others (Sobolevsky and Yelshansky, 2000) argue against the idea (Kampa et al., 2004; Vargas-Caballero and Robinson, 2004 ) that block by Mg It is perhaps surprising that occupation of an ion channel by a relatively large molecule such as amantadine would accelerate rather than slow channel closure. Stabilization of closed states of a mutant Shaker K ϩ channel by an organic channel blocker has been observed previously (Holmgren et al., 1997) . Tetraethylammonium (TEA) and its analog C 10 strongly stabilize the open state of wild-type Shaker channels. However, when Shaker channels with a point mutation (I470C) near the middle of the S6 region were examined, C 10 was found to weakly stabilize the channel open state and TEA to weakly stabilize channel closed states. These results indicate that the precise relationship between blocker structure and the shape of the channel cavity in which blockers are likely to bind (Jiang and MacKinnon, 2000) can determine the effects of blocker binding on channel gating. Structural and functional similarities between K ϩ channels and glutamate receptors (Panchenko et al., 2001 ) suggest that similar ideas may apply to block of NMDA receptors. Thus, systematic molecular modification of amantadine and other blockers (Antonov and Johnson, 1996; Bolshakov et al., 2003) can be used to help define channel shape while advancing the search for more useful therapeutic drugs.
Amantadine and its close analog memantine are both NMDA channel blockers that exhibit high clinical utility. Their spectra of utility, however, differ substantially (Danysz et al., 1997) ; for example, amantadine appears to be the more effective antiparkinsonian drug, whereas memantine currently is the only drug approved by the FDA for use in the treatment of moderate to severe Alzheimer's disease. Correspondingly, each drug exhibits distinct antagonistic properties that influence their affinity, kinetics, ability to be trapped, and use dependence. The properties of amantadine described here permit its action to resemble in important respects block by Mg 2ϩ o , although amantadine block is less voltage dependent because of the lower valence of the drug (ϩ1 at physiological pH). Thus, the remarkably fast unblocking kinetics of amantadine allow it, like Mg 2ϩ o , to at least partly unblock during the brief depolarization of an action potential, a characteristic that may decrease deleterious clinical effects. The weaker voltage dependence of amantadine should permit it to inhibit NMDA responses more effectively than Mg 2ϩ o during the prolonged depolarizations that accompany neurological insults, enhancing its neuroprotective potential. Together, the unique combination of kinetics, effects on channel gating, and voltage dependence of amantadine may enhance both its clinical safety and effectiveness. . Current relaxations at 40 mV were fit using either a double (agonists with 0 blocker or 100 M Mg 2ϩ ) or a triple (agonists with 100 M amantadine) exponential equation. A is the fractional amplitude of each component.
